Off- vs. On-Pump Coronary Artery Bypass Grafting Long-Term Survival is Driven by Incompleteness of Revascularisation

Udit Thakur1, Nitesh Nerlekar2, Rahul G Muthalaly1

  • 1Monash Cardiovascular Research Centre, Monash University and MonashHeart, Monash Health, Melbourne, Vic, Australia; Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Melbourne, Vic, Australia.

Heart, Lung & Circulation
|January 29, 2019
PubMed

Insights

Off-pump coronary artery bypass grafting (CABG) shows higher long-term mortality and need for repeat procedures compared to on-pump CABG. This suggests on-pump CABG may offer better long-term outcomes due to reduced revascularization requirements.

Area of Science:

  • Cardiovascular Surgery
  • Surgical Outcomes Research

Background:

  • Off-pump coronary artery bypass grafting (CABG) avoids extracorporeal circulation but is technically demanding, potentially leading to incomplete revascularization.
  • On-pump CABG may offer prognostic benefits, but the underlying mechanisms require clarification.
  • This study investigates if repeat revascularization drives long-term outcome differences between on-pump and off-pump CABG.

Purpose of the Study:

  • To evaluate short, medium, and long-term outcomes of on-pump versus off-pump coronary artery bypass grafting (CABG).
  • To determine if increased need for repeat revascularization in off-pump CABG contributes to long-term mortality differences.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) with at least 100 patients per arm.
  • Included studies were searched from electronic databases.
  • Primary outcome was long-term all-cause mortality; secondary outcomes included cardiac death, stroke, myocardial infarction, and repeat revascularization at 30 days, 12 months, and >4 years.

Main Results:

  • Thirteen RCTs involving 13,234 patients were analyzed.
  • Off-pump CABG was linked to higher long-term all-cause mortality (OR 1.18) and increased need for repeat bypass surgery (OR 2.57).
  • A significant increase in revascularization for off-pump CABG was observed at 12 months (OR 1.59); no significant differences in stroke or myocardial infarction were found.

Conclusions:

  • Off-pump CABG is associated with significantly higher long-term all-cause mortality.
  • This increased mortality may be attributed to a greater requirement for repeat revascularization at 1- and 5-year follow-ups.
  • On-pump CABG may provide superior long-term prognostic benefits.
Abstract

Related Concept Videos

ATP Driven Pumps II: P-type Pumps01:34

ATP Driven Pumps II: P-type Pumps

The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
6.4K
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
4.8K
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
9.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
426
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267